Can I read Amycretin in Obesity on EtoBox?

Amycretin in Obesity by nandiniilayaraja is a document available to read on EtoBox.

What is Amycretin in Obesity about?

The review discusses amycretin, a novel unimolecular co-agonist targeting GLP-1 and amylin receptors, as a promising therapeutic option for obesity management. Clinical trials indicate significant weight loss with amycretin, achieving up to 24.3% reduction over 36 weeks, while maintaining a favorable safety profile. The review also explores the potential of combining amycretin with other agents to enhance treatment outcomes for obesity-related chronic diseases.

Author

nandiniilayaraja

Language

EN